Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China

Baseline and on-treatment characteristics, including age, obesity, calcium intake, and bone turnover markers, may predict the bone mineral density (BMD) response in women with postmenopausal osteoporosis (PMO) to 1 to 2 years of antiresorptive therapy and/or vitamin D supplementation. This study aim...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicine (Baltimore) 2018-08, Vol.97 (31), p.e11694-e11694
Hauptverfasser:	Liao, Er-Yuan, Zhang, Zhen-Lin, Xia, Wei-Bo, Lin, Hua, Cheng, Qun, Wang, Li, Hao, Yong-Qiang, Chen, De-Cai, Tang, Hai, Peng, Yong-De, You, Li, He, Liang, Hu, Zhao-Heng, Song, Chun-Li, Wei, Fang, Wang, Jue, Zhang, Lei
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Alendronate - administration & dosage Bone Density - drug effects Bone Density Conservation Agents - administration & dosage Calcitriol - administration & dosage China Cholecalciferol - administration & dosage Dietary Supplements Female Humans Lumbar Vertebrae - physiopathology Middle Aged Observational Study Osteoporosis, Postmenopausal - drug therapy Osteoporosis, Postmenopausal - physiopathology Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!